I can't say I'm thrilled that someone from STEM is moderating a panel discussion next week called "Unproven Stem Cell Therapies and Deceptive Claims: Hidden Dangers to Patients". The title doesn't exactly inspire confidence, although I suppose STEM will try to make their case for stemcell therapy vs. doing nothing.
Trading volume on STEM is pathetic today, by the way. Just not a lot of interest here right now. Looks like this is going to be a "wait 'til next year" situation, because I don't see much coming out of STEM for the rest of 2012. I do think STEM's share price will do very well in the first few months of 2013, however.